An interventional study of Flexible and Navigable Suction Ureteral Access Sheath (FANS-UAS) in Urolithiasis, Kidney Calculi and Ureteral Calculi, sponsored by Misr University for Science and Technology. Not yet recruiting at 1 site in Egypt. Open to participants aged 6 Years to 16 Years. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Misr University for Science and Technology · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 25 studies in Urolithiasis with a site in Egypt — 7 open to participants now, 10 under way, 1 of them phase 3. Urolithiasis · Egypt.
Among the 25 studies in Urolithiasis with a site in Egypt, this one is the 20th largest by planned enrollment of the 22 interventional ones that give a count, is one of 5 that started in 2026, is one of 16 with no phase, and was the 25th registered.
255 studies on the registry are indexed under Urolithiasis; 68 are open to participants now.
Browse Urolithiasis studies →7 of the 25 studies in Urolithiasis with a site in Egypt are open now. Recruiting first, the newest first:
Al-Azhar University · Sites in Egypt
Ages 18+
Beni-Suef University · Sites in Egypt
Ages 18–60
Beni-Suef University · Sites in Egypt
Ages 18+
Mansoura University · Sites in Egypt
Ages 2–18 · Healthy volunteers
Mansoura University · Sites in Egypt
Ages 18+
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 38 Urolithiasis studies recruiting now, 18 (47%) set no upper age limit and 12 (32%) stop at 75 or younger; 5 take children under 18; 4 take healthy volunteers.
This study: 6 Years to 16 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
25 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 2 · Phase 3 2 · Phase 4 3
First in 2015; this study’s year is marked. 5 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 50 is below the median of 100 across 184 interventional studies indexed under Urolithiasis.
Median enrollment 145 across the 22 interventional studies, 110 across the 3 observational. Of the 13 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 25 has an industry lead sponsor. The 10 most frequent:
Misr University for Science and Technology is the lead sponsor of 39 studies on the registry; 16 are open to participants now.
Misr University for Science and Technology has 1 study filed under Urolithiasis — fewer than ten, so there is no comparison to draw.
3 of the studies in Urolithiasis with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07295860Mansoura UniversityFANS-FURS vs Suction Mini-PCNL for 2-3 cm Renal Stones: A Multicenter Randomized Trial | 2027-01-01 |
| NCT07627828Beni-Suef UniversityComfiJ Versus Conventional Double-J Stent for Ureteral Stent Symptoms | 2027-04 |
| NCT07939438Misr University for Science and TechnologyPostoperative Stenting After Flexible Ureteroscopy in Children With Upper Urinary Tract Stones | 2027-05-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 25 studies in Urolithiasis with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to evaluate whether postoperative double-J ureteral stent placement can be safely avoided in children undergoing flexible ureteroscopy using a flexible and navigable suction ureteral access sheath (FANS-UAS) for upper urinary tract stones.
The study will include 50 children aged 6-16 years with upper urinary tract stones measuring 1-2 cm who undergo flexible ureteroscopy at Ain Shams University Hospitals.
During the procedure, a suction-assisted ureteral access sheath will be used to facilitate stone fragmentation and removal. The decision to place a postoperative ureteral stent will be based on intraoperative findings and the surgeon's assessment.
The study will assess the need for postoperative stenting, stone clearance, postoperative pain, fever, and other procedure-related complications to determine whether flexible and navigable suction ureteral access sheath (FANS-UAS) can reduce unnecessary stent placement while maintaining procedural safety and effectiveness.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
All participants will undergo retrograde intrarenal surgery (RIRS) using flexible ureteroscopy assisted by a flexible and navigable suction ureteral access sheath (FANS-UAS) for the treatment of upper urinary tract stones. Laser lithotripsy will be performed using a holmium:YAG laser, with suction-assisted evacuation of stone fragments. The decision to place a postoperative double-J ureteral stent will be based on intraoperative findings, including residual stones, ureteral wall injury, bleeding, operative time, and surgeon discretion. Participants will undergo postoperative follow-up for one month.
Device: Flexible and Navigable Suction Ureteral Access Sheath (FANS-UAS)
A 9.5 Fr suction ureteral access sheath (ClearPetra) will be inserted into the ureter during retrograde intrarenal surgery (RIRS). The sheath tip will be positioned in the renal pelvis or calyces near the stone and connected to a suction device. Negative pressure will be adjusted intraoperatively to facilitate irrigation fluid drainage, maintain visualization, and evacuate stone fragments during holmium:YAG laser lithotripsy. The procedure will be performed using a 7.5 Fr flexible ureteroscope.
Successful Avoidance of Postoperative Double-J Ureteral Stenting
Proportion of patients in whom postoperative double-J ureteral stent placement is avoided following flexible ureteroscopy using FANS-UAS without requiring an additional postoperative intervention during follow-up.
Time frame: Up to 1 month after surgery
Stone-Free Rate Following Flexible Ureteroscopy
Proportion of patients without residual stone fragments larger than 4 mm, assessed using kidney, ureter, and bladder (KUB) radiography and non-contrast computed tomography of the urinary tract (NCCTUT).
Time frame: Up to 1 month after surgery
Postoperative Pain Score
Postoperative pain severity assessed using a visual analogue scale (VAS) ranging from 1 to 10, with higher scores indicating greater pain intensity.
Time frame: Up to 1 month after surgery
Incidence of Postoperative Fever
Proportion of patients experiencing postoperative fever following FANS-UAS-assisted flexible ureteroscopy.
Time frame: Up to 1 month after surgery
Operative Time
Duration of the surgical procedure, measured in minutes.
Time frame: During surgery
Incidence of Ureteric Stricture
Proportion of patients diagnosed with ureteric stricture during postoperative follow-up.
Time frame: Up to 1 month after surgery
Incidence of Calyceal Rupture
Proportion of patients experiencing calyceal rupture during the surgical procedure.
Time frame: During surgery
Start is estimated for Nov 2026; primary completion for May 2027, 6 months later.
Of 87 non-industry interventional studies with no phase under Urolithiasis, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 40. This study's planned 6 months is below that.
Counting every sponsor, half of 97 studies reached it within 19 months; a quarter within 11 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Misr University for Science and Technology